Table 1.
Subtype | Year | Age (x ± s) | Men (%) | Urban area (%) | Number | Percentage (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stroke | Dizziness | Headache | Anxiety/depression | PN | Insomnia | Epilepsy | Dementia | PD | Others | ||||||
Outpatient | 2019 | 54.6 ± 16.3 | 42.7 | 51.2 | 102300 | (16.9) | (16.2) | (16.0) | (13.7) | (10.3) | (9.4) | (3.3) | (2.3) | (5.3) | (6.6) |
2020 | 55.8 ± 16.5 | 43.2 | 55.8 | 75154 | (16.8) | (13.7) | (12.3) | (15.9) | (9.8) | (12.3) | (5.1) | (2.6) | (5.0) | (6.5) | |
χ2 | 1.49 | 90.78 | 0.02 | 51.58 | 1.22 | 43.53 | 2.58 | 94.19 | 54.67 | 4.05 | 1.82 | 1.32 | |||
P | 0.22 | 0.00 | 0.88 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.04 | 0.18 | 0.25 |
Pearson’s Chi-square test and relative p value were performed to compare the proportion in 2019 and 2020. p < 0.05 was considered statistically significant. PN: peripheral neuropathy, PD: Parkinson/parkinsonism diseases